Holen Sie sich die Stockscreener-App
284.07
0.84%
-2.42
Handel nachbörslich:
284.07
Schlusskurs vom Vortag:
$286.49
Offen:
$285.51
24-Stunden-Volumen:
387.68K
Relative Volume:
1.34
Marktkapitalisierung:
$6.25B
Einnahmen:
$2.58B
Nettoeinkommen (Verlust:
$-778.69M
KGV:
-10.39
EPS:
-27.33
Netto-Cashflow:
$223.75M
1W Leistung:
+1.33%
1M Leistung:
-1.49%
6M Leistung:
+11.76%
1J Leistung:
-17.57%
1-Tages-Spanne:
$282.72
$287.27
1-Wochen-Bereich:
$276.49
$288.15
52-Wochen-Spanne:
$211.43
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Firmenname
Bio Rad Laboratories Inc
Sektor
Branche
Telefon
(510) 724-7000
Adresse
1000 ALFRED NOBEL DRIVE, HERCULES
Vergleichen Sie BIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
284.07 | 7.75B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
136.04 | 234.21B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
97.83 | 145.55B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
376.83 | 144.45B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.08 | 122.61B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.41 | 43.77B | 5.69B | 1.41B | 577.90M | 6.95 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-03 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-12-07 | Eingeleitet | UBS | Buy |
| 2023-06-16 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-01-28 | Bestätigt | Citigroup | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2018-10-17 | Eingeleitet | Goldman | Buy |
| 2018-09-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Herabstufung | CL King | Buy → Neutral |
| 2017-07-13 | Eingeleitet | Wells Fargo | Outperform |
| 2017-06-28 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Eingeleitet | Deutsche Bank | Hold |
| 2016-10-13 | Eingeleitet | CL King | Buy |
| 2015-05-06 | Bestätigt | Jefferies | Buy |
| 2009-12-18 | Eingeleitet | Maxim Group | Buy |
| 2009-11-06 | Eingeleitet | Jefferies & Co | Buy |
| 2009-07-17 | Eingeleitet | Soleil | Buy |
| 2007-09-26 | Eingeleitet | Banc of America Sec | Buy |
| 2007-02-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Bio Rad Laboratories Inc Aktie (BIO) Neueste Nachrichten
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap UpStill a Buy? - MarketBeat
Retail Surge: Is Bio Rad Laboratories Inc stock risky to hold nowPrice Action & Entry Point Confirmation Alerts - khodrobank.com
Stock Recap: Is ALX Oncology Holdings Inc stock forming a triangle patternDollar Strength & Weekly Stock Breakout Alerts - khodrobank.com
Swedbank AB Has $731,000 Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
RSI Check: Is Bio Rad Laboratories Inc likely to announce a buyback2025 Trade Ideas & AI Forecast Swing Trade Picks - khodrobank.com
Aug Setups: What is the long term forecast for Bio Rad Laboratories Inc stock2025 Major Catalysts & Intraday High Probability Setup Alerts - khodrobank.com
Peptone Market Hits New High | Major Giants Solabia,Condalab,Bio-Rad - openPR.com
S&P 500 Futures Flat in Premarket Trading; Bio-Rad Labs B, Klaviyo Lead - Barron's
United States Custom Antibody Services Market Industry Outlook - openPR.com
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $93.24 Million Stock Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Jacobs Levy Equity Management Inc. Invests $816,000 in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
United Services Automobile Association Buys Shares of 1,202 Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Market Overview: What’s the RSI of Bio Rad Laboratories Inc. stockJuly 2025 Reactions & Long-Term Safe Investment Plans - khodrobank.com
Trends Shaping the Automated Microbiology 2025-2030: Revenues to Surge by $4.65 Billion, Totalling $12.52 Billion in 2030 - GlobeNewswire Inc.
Market Review: Is Bio Rad Laboratories Inc. stock overvalued or fairly priced2025 Price Targets & Smart Investment Allocation Tips - khodrobank.com
Bio-Rad Laboratories, Inc. (BIO) Launches New Instruments, Boosts Molecular Testing Reach - Yahoo Finance
US NGS Market Forecast and Company Analysis Report - GlobeNewswire
US NGS Market Forecast and Company Analysis Report 2025-2033: Illumina, Thermo Fisher Scientific, Pacific Biosciences, QIAGEN, Roche, Bio-Rad Laboratories, Takara Bio, Hamilton, Geneious, BioMerieux - Yahoo Finance
United States Flow Cytometry Market Poised for Breakthrough - openPR.com
Value Recap: What is MDIA’s TAM (Total Addressable Market)Weekly Investment Summary & Smart Allocation Stock Tips - خودرو بانک
United States CRISPR Market Surge Fueled by Genomic Medicine & - openPR.com
What drives Bio Rad Laboratories Incs stock price2025 Fundamental Recap & Real-Time Buy Signal Alerts - khodrobank.com
Acadian Asset Management LLC Boosts Stock Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Caxton Associates LLP Takes $730,000 Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Valuation Update: Whats the RSI of Bio Rad Laboratories Inc stockForecast Cut & Free Reliable Trade Execution Plans - khodrobank.com
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap DownShould You Sell? - MarketBeat
Volatility Watch: Is Bio Rad Laboratories Inc a cyclical or defensive stock2025 Technical Overview & Stepwise Entry and Exit Trade Signals - khodrobank.com
Published on: 2025-09-16 13:29:49 - khodrobank.com
Bearish Setup: Will Bio Rad Laboratories Inc benefit from geopolitical trendsDividend Hike & AI Based Trade Execution Alerts - خودرو بانک
Amundi Increases Stock Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Published on: 2025-09-16 09:14:46 - khodrobank.com
Activity Recap: Is Bio Rad Laboratories Incs ROE strong enough2025 Geopolitical Influence & Reliable Price Action Trade Plans - khodrobank.com
Rally Mode: Is now the right time to enter Bio Rad Laboratories Inc2025 Earnings Impact & Fast Gain Stock Tips - خودرو بانک
Bio-Rad Launches EZ-Check Salmonella Kit - Quality Assurance & Food Safety
Retail Trends: What are Bio Rad Laboratories Inc.’s earnings expectations2025 Fundamental Recap & Daily Chart Pattern Signals - خودرو بانک
Earnings Beat: What is the long term forecast for Bio Rad Laboratories Inc stockTake Profit & Free Daily Entry Point Trade Alerts - خودرو بانک
US Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic - GlobeNewswire
Bio-Rad Launches EZ-Check Salmonella spp. Kit for Detection of Salmonella spp. in Food and Environmental Samples - Quality Assurance & Food Safety
We Think Bio-Rad Laboratories (NYSE:BIO) Can Stay On Top Of Its Debt - 富途牛牛
Analyzing Bio Rad Laboratories Inc. with multi timeframe chartsJuly 2025 Patterns & Fast Moving Trade Plans - newser.com
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down – Time to Sell? - Defense World
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Reduces Holdings in Bio-Rad Laboratories, Inc. $BIO - Defense World
Jacobs Levy Equity Management Inc. Purchases New Position in Bio-Rad Laboratories, Inc. $BIO - Defense World
Select Equity Group L.P. Lowers Stock Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Millennium Management LLC Sells 41,025 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Petrus Trust Company LTA Has $688,000 Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Protein Purification & Isolation Market Set for Significant - openPR.com
Protein Detection and Quantification Market Fueled by 9.6% CAGR - openPR.com
Finanzdaten der Bio Rad Laboratories Inc-Aktie (BIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
1.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):